PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Cholangiocarcinoma D018281 7 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Leukemia, Megakaryoblastic, Acute D007947 7 associated lipids
Thrombophilia D019851 6 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Fetal Alcohol Spectrum Disorders D063647 6 associated lipids
Sneezing D012912 6 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
PPAR activators and gastroenterology. 2004 Drug News Perspect. pmid:15801147
Kasim-Karakas SE et al. Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome. 2004 J. Clin. Endocrinol. Metab. pmid:14764771
Hirai H [Prostaglandin D2 in allergy: PGD2 has dual receptor systems]. 2004 Nippon Yakurigaku Zasshi pmid:14695454
Uehara Y [PGD(2)/L-PGDS system in hypertension and renal injury]. 2004 Nippon Yakurigaku Zasshi pmid:14695455
Miwa Y et al. Physiology and pharmacology of the prostaglandin J2 family. 2004 Nippon Yakurigaku Zasshi pmid:14695456
Fernández-Tome M et al. COX-2-mediated PGD2 synthesis regulates phosphatidylcholine biosynthesis in rat renal papillary tissue. 2004 Biochem. Pharmacol. pmid:14698037
Matsuo T et al. 15d-PGJ2 inhibits oxidized LDL-induced macrophage proliferation by inhibition of GM-CSF production via inactivation of NF-kappaB. 2004 Biochem. Biophys. Res. Commun. pmid:14741709
Józkowicz A et al. Opposite effects of prostaglandin-J2 on VEGF in normoxia and hypoxia: role of HIF-1. 2004 Biochem. Biophys. Res. Commun. pmid:14715242
Neuhofer W et al. Chronic COX-2 inhibition reduces medullary HSP70 expression and induces papillary apoptosis in dehydrated rats. 2004 Kidney Int. pmid:14717913
Ward JE et al. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms. 2004 Br. J. Pharmacol. pmid:14718259
Ray DM et al. Human multiple myeloma cells express peroxisome proliferator-activated receptor gamma and undergo apoptosis upon exposure to PPARgamma ligands. 2004 Clin. Immunol. pmid:15451478
Abdelrahman M et al. The peroxisome proliferator-activated receptor-gamma ligand 15-deoxyDelta12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock. 2004 Shock pmid:15545828
Chen F Endogenous inhibitors of nuclear factor-kappaB, an opportunity for cancer control. 2004 Cancer Res. pmid:15548674
Inoue K et al. Effects of 15-deoxy-delta12,14-prostaglandin J2 on the cyclooxygenase-2 expression in the murine lung in the presence of lipopolysaccharide. 2004 Arzneimittelforschung pmid:15612612
Mitsumori S Recent progress in work on PGD2 antagonists for drugs targeting allergic diseases. 2004 Curr. Pharm. Des. pmid:15579050
Arai I et al. Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis. 2004 Eur. J. Pharmacol. pmid:15556157
Chen Q et al. A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist. 2004 Anal. Biochem. pmid:15556564
Kim BE et al. Involvement of Sox-4 in the cytochrome c-dependent AIF-independent apoptotic pathway in HeLa cells induced by Delta12-prostaglandin J2. 2004 Exp. Mol. Med. pmid:15557816
Cheng S et al. Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1. 2004 J. Biol. Chem. pmid:15023995
Alvarez-Maqueda M et al. 15-deoxy-delta 12,14-prostaglandin J2 induces heme oxygenase-1 gene expression in a reactive oxygen species-dependent manner in human lymphocytes. 2004 J. Biol. Chem. pmid:15024026
Marone G et al. The human heart as a shock organ in anaphylaxis. 2004 Novartis Found. Symp. pmid:15025396
Qin C et al. A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes. 2004 Mol. Cancer Ther. pmid:15026545
Hashimoto K et al. Activation and role of MAP kinases in 15d-PGJ2-induced apoptosis in the human pancreatic cancer cell line MIA PaCa-2. 2004 Pancreas pmid:15028947
Toyomoto M et al. Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures. 2004 FEBS Lett. pmid:15044028
Tanaka K et al. Effects of prostaglandin D2 on helper T cell functions. 2004 Biochem. Biophys. Res. Commun. pmid:15044085
Onozaki A et al. Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione. 2004 Biochem. Biophys. Res. Commun. pmid:15047143
Koda N et al. Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MS. 2004 Arch. Biochem. Biophys. pmid:15047184
Saydam O et al. Transactivator protein BICP0 of bovine herpesvirus 1 (BHV-1) is blocked by prostaglandin D2 (PGD2), which points to a mechanism for PGD2-mediated inhibition of BHV-1 replication. 2004 J. Virol. pmid:15047795
Tsuji T et al. Differential effects of beta2-adrenoceptor desensitization on the IgE-dependent release of chemical mediators from cultured human mast cells. 2004 Biol. Pharm. Bull. pmid:15467193
Konopleva M et al. Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. 2004 Mol. Cancer Ther. pmid:15486192
Liu JD et al. Thiol antioxidant and thiol-reducing agents attenuate 15-deoxy-delta 12,14-prostaglandin J2-induced heme oxygenase-1 expression. 2004 Life Sci. pmid:14998722
Hayashi N et al. Antitumor effects of peroxisome proliferator activate receptor gamma ligands on anaplastic thyroid carcinoma. 2004 Int. J. Oncol. pmid:14654945
Zhang X et al. Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in human mesangial cells. 2004 Kidney Int. pmid:14871400
Ueta M et al. PPARgamma ligands attenuate mesangial contractile dysfunction in high glucose. 2004 Kidney Int. pmid:14871416
Badawi AF et al. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. 2004 Cancer Res. pmid:14871855
Weber SM et al. PPARgamma is not required for the inhibitory actions of PGJ2 on cytokine signaling in pancreatic beta-cells. 2004 Am. J. Physiol. Endocrinol. Metab. pmid:14600076
Yoshimura-Uchiyama C et al. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2. 2004 Clin. Exp. Allergy pmid:15298571
Kielian T et al. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2). 2004 J. Neurochem. pmid:15312171
Weber SM et al. PPARgamma ligands induce ER stress in pancreatic beta-cells: ER stress activation results in attenuation of cytokine signaling. 2004 Am. J. Physiol. Endocrinol. Metab. pmid:15315910
Szczeklik W et al. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. 2004 J. Allergy Clin. Immunol. pmid:15316498
Siavash H et al. Abrogation of IL-6-mediated JAK signalling by the cyclopentenone prostaglandin 15d-PGJ(2) in oral squamous carcinoma cells. 2004 Br. J. Cancer pmid:15316561
Sánchez-Gómez FJ et al. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes. 2004 Mol. Pharmacol. pmid:15317873
Shahab R et al. Prostaglandins, leukotrienes and perennial rhinitis. 2004 J Laryngol Otol pmid:15318955
Lim SY et al. 15-Deoxy-Delta12,14-prostaglandin J(2) protects against nitrosative PC12 cell death through up-regulation of intracellular glutathione synthesis. 2004 J. Biol. Chem. pmid:15319433
Sasaguri T and Miwa Y Prostaglandin J2 family and the cardiovascular system. 2004 Curr Vasc Pharmacol pmid:15320511
Servidei T et al. The cellular response to PPARgamma ligands is related to the phenotype of neuroblastoma cell lines. 2004 Oncol. Res. pmid:15301425
Boyault S et al. 15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway. 2004 FEBS Lett. pmid:15304320
Ichiki T et al. 15-Deoxy-Delta12,14-prostaglandin J2 and thiazolidinediones transactivate epidermal growth factor and platelet-derived growth factor receptors in vascular smooth muscle cells. 2004 Biochem. Biophys. Res. Commun. pmid:15369766
Shimomura K et al. Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion. 2004 J. Pharmacol. Exp. Ther. pmid:15201343
Hawcroft G et al. Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells. 2004 Cancer Lett. pmid:15172124
Son DJ et al. Antiplatelet effect of green tea catechins: a possible mechanism through arachidonic acid pathway. 2004 Prostaglandins Leukot. Essent. Fatty Acids pmid:15172681
Takeshita K et al. CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation. 2004 Int. Immunol. pmid:15173122
Cipollone F et al. Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. 2004 Arterioscler. Thromb. Vasc. Biol. pmid:15155382
Ward C et al. Regulation of granulocyte apoptosis by NF-kappaB. 2004 Biochem. Soc. Trans. pmid:15157161
Miwa Y et al. Involvement of clusterin in 15-deoxy-delta12,14-prostaglandin J2-induced vascular smooth muscle cell differentiation. 2004 Biochem. Biophys. Res. Commun. pmid:15158456
Hsu MF et al. Inhibition of the arachidonic acid cascade by norathyriol via blockade of cyclooxygenase and lipoxygenase activity in neutrophils. 2004 Naunyn Schmiedebergs Arch. Pharmacol. pmid:15083266
Karimi K et al. Substance P can stimulate prostaglandin D2 and leukotriene C4 generation without granule exocytosis in murine mast cells. 2004 Eur. J. Pharmacol. pmid:15063154
Chana RS et al. Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists. 2004 Kidney Int. pmid:15149321
Garg TK and Chang JY 15-deoxy-delta 12, 14-Prostaglandin J2 prevents reactive oxygen species generation and mitochondrial membrane depolarization induced by oxidative stress. 2004 BMC Pharmacol. pmid:15149553
Moore RM et al. Physiological apoptotic agents have different effects upon human amnion epithelial and mesenchymal cells. 2003 Feb-Mar Placenta pmid:12566244
Kanaoka Y and Urade Y Hematopoietic prostaglandin D synthase. 2003 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:12895599
Nagata K and Hirai H The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes. 2003 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:12895600
Powell WS A novel PGD(2) receptor expressed in eosinophils. 2003 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:12895601
Kabashima K and Narumiya S The DP receptor, allergic inflammation and asthma. 2003 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:12895602
Honda K et al. Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine. 2003 J. Exp. Med. pmid:12925672
Mendez M and LaPointe MC PPARgamma inhibition of cyclooxygenase-2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes. 2003 Hypertension pmid:12885795
Li L et al. Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts. 2003 Gastroenterology pmid:12891549
Vosseler CA et al. Structural requirements of cyclopentenone prostaglandins to induce endothelial cell apoptosis. 2003 Biochem. Biophys. Res. Commun. pmid:12859958
Aoun P et al. Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells. 2003 Eur. J. Pharmacol. pmid:12860474
Zanoni G et al. First total synthesis of JS isoprostane. 2003 J. Org. Chem. pmid:12868940
Zahradka P et al. Activation of peroxisome proliferator-activated receptors alpha and gamma1 inhibits human smooth muscle cell proliferation. 2003 Mol. Cell. Biochem. pmid:12841350
Yang L et al. Peroxisome proliferator-activated receptor gamma and ligands inhibit surfactant protein B gene expression in the lung. 2003 J. Biol. Chem. pmid:12829715
Houston KD et al. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma. 2003 Cancer Res. pmid:12649180
Adachi H et al. Molecular characterization of human and rat organic anion transporter OATP-D. 2003 Am. J. Physiol. Renal Physiol. pmid:14631946
Mueller C et al. Peroxisome proliferator-activated receptor gamma ligands attenuate immunological symptoms of experimental allergic asthma. 2003 Arch. Biochem. Biophys. pmid:14522590
Piliponsky AM et al. Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. 2003 Blood pmid:12393403
Yuan Z et al. Peroxisome proliferation-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis. 2003 Cardiovasc. Res. pmid:14499870
Cuzzocrea S et al. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. 2003 Br. J. Pharmacol. pmid:12970094
Farrow B et al. Selective activation of PPARgamma inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator. 2003 Surgery pmid:12947319
Zhang M et al. Peroxisome proliferator-activated receptor-gamma activated by ligands can inhibit human lung cancer cell growth through induction of apoptosis. 2003 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:12973930
Powell WS 15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product? 2003 J. Clin. Invest. pmid:12975467
Chen YX et al. 15d-PGJ2 inhibits cell growth and induces apoptosis of MCG-803 human gastric cancer cell line. 2003 World J. Gastroenterol. pmid:14562367
Bell-Parikh LC et al. Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. 2003 J. Clin. Invest. pmid:12975479
Shichijo M et al. Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats. 2003 J. Pharmacol. Exp. Ther. pmid:12975488
Gilroy DW et al. Inducible cyclooxygenase-derived 15-deoxy(Delta)12-14PGJ2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis. 2003 FASEB J. pmid:14563690
Pierzchalska M et al. Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma. 2003 J. Allergy Clin. Immunol. pmid:12743569
Okano H et al. 15-deoxy-delta-12-14-PGJ2 regulates apoptosis induction and nuclear factor-kappaB activation via a peroxisome proliferator-activated receptor-gamma-independent mechanism in hepatocellular carcinoma. 2003 Lab. Invest. pmid:14563954
Jowsey IR et al. Expression of the murine glutathione S-transferase alpha3 (GSTA3) subunit is markedly induced during adipocyte differentiation: activation of the GSTA3 gene promoter by the pro-adipogenic eicosanoid 15-deoxy-Delta12,14-prostaglandin J2. 2003 Biochem. Biophys. Res. Commun. pmid:14652005
Hammad H et al. Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. 2003 J. Immunol. pmid:14530310
Imaizumi T et al. 15-deoxy-delta(12,14)-prostaglandin J2 inhibits IFN-gamma-induced galectin-9 expression in cultured human umbilical vein endothelial cells. 2003 Int. Arch. Allergy Immunol. pmid:12759491
Sommer A et al. A dominant role for extracellular glutathione S-transferase from Onchocerca volvulus is the production of prostaglandin D2. 2003 Infect. Immun. pmid:12761146
Irikura D et al. Cloning, expression, crystallization, and preliminary X-ray analysis of recombinant mouse lipocalin-type prostaglandin D synthase, a somnogen-producing enzyme. 2003 J. Biochem. pmid:12761195
Shibata T et al. Thioredoxin as a molecular target of cyclopentenone prostaglandins. 2003 J. Biol. Chem. pmid:12709421
Zhuang H et al. Regulation of heme oxygenase expression by cyclopentenone prostaglandins. 2003 Exp. Biol. Med. (Maywood) pmid:12709576
Kämpfer H et al. Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair. 2003 J. Invest. Dermatol. pmid:12713596
Brown JR et al. Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD). 2003 J. Leukoc. Biol. pmid:12714573
Winnett G et al. Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy. 2003 Int. J. Cancer pmid:12494466
Kalla R et al. Loss of microglial ramification in microglia-astrocyte cocultures: involvement of adenylate cyclase, calcium, phosphatase, and Gi-protein systems. 2003 Glia pmid:12465045
Arici M et al. Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-gamma. 2003 J. Am. Soc. Nephrol. pmid:12506134
Hirano A et al. Arachidonic acid-induced channel- and carrier-type ion transport across planar bilayer lipid membranes. 2003 Anal Sci pmid:12608744